Current Perspectives and Barriers in Pharmacovigilance: Implications for Pharmacy Practice

Pharmacovigilance (PV) is critical for identifying, assessing, and preventing adverse drug reactions (ADRs), which significantly burden global healthcare systems. India’s Pharmacovigilance Programme of India (PvPI) serves as the primary mechanism for drug safety monitoring. Recent developments include the integration of electronic health records, artificial intelligence (AI) for signal detection, patient-reporting platforms, and social media surveillance. Nonetheless, persistent challenges such as under-reporting, inadequate training, resource limitations, and low awareness continue to impede optimal PV implementation [1– 3]. Pharmacists, with their specialized knowledge, are uniquely positioned to improve PV through detection, reporting, and patient counseling. This review evaluates technological advancements, discusses pharmacists’ roles, identifies challenges, and proposes strategies for strengthening PV systems. Enhanced pharmacist engagement and technology adoption hold promise for improved medication safety and public confidence

Authors

Institutions

Publication Details

Journal
International Journal of Pharmaceutical Research and Applications
Published
2025-04-01
DOI
https://doi.org/10.35629/4494-1004883884
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Current Perspectives and Barriers in Pharmacovigilance: Implications for Pharmacy Practice

S Sabitha
International Journal of Pharmaceutical Research and Applications
Pharmacovigilance and Adverse Drug Reactions
article

Current Perspectives and Barriers in Pharmacovigilance: Implications for Pharmacy Practice

S Sabitha
article en

Abstract

Pharmacovigilance (PV) is critical for identifying, assessing, and preventing adverse drug reactions (ADRs), which significantly burden global healthcare systems. India’s Pharmacovigilance Programme of India (PvPI) serves as the primary mechanism for drug safety monitoring. Recent developments include the integration of electronic health records, artificial intelligence (AI) for signal detection, patient-reporting platforms, and social media surveillance. Nonetheless, persistent challenges such as under-reporting, inadequate training, resource limitations, and low awareness continue to impede optimal PV implementation [1– 3]. Pharmacists, with their specialized knowledge, are uniquely positioned to improve PV through detection, reporting, and patient counseling. This review evaluates technological advancements, discusses pharmacists’ roles, identifies challenges, and proposes strategies for strengthening PV systems. Enhanced pharmacist engagement and technology adoption hold promise for improved medication safety and public confidence

International Journal of Pharmaceutical Research and ApplicationsVol. 10(4)
Klinik und Poliklinik für Psychosomatik und Psychotherapie (DE)
Openalex Percentile: Top 79%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.